Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-26-202429
Filing Date
2026-05-04
Accepted
2026-05-04 06:30:27
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d83075d424b5.htm 424B5 224446
2 GRAPHIC g83075g01a03.jpg GRAPHIC 30964
  Complete submission text file 0001193125-26-202429.txt   268227
Mailing Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758
Business Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758 7378021989
Rein Therapeutics, Inc. (Filer) CIK: 0001420565 (see all company filings)

EIN.: 134196017 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-295390 | Film No.: 26934552
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)